Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-06-013854
Filing Date
2006-11-09
Accepted
2006-11-09 15:56:24
Documents
6
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y26939e10vq.htm 10-Q 378143
2 EX-10.1: 1999 INCENTIVE AND NON-QUALIFIED STOCK OPTION PLAN y26939exv10w1.htm EX-10.1 47655
3 EX-31.1: CERTIFICATION y26939exv31w1.htm EX-31.1 6495
4 EX-31.2: CERTIFICATION y26939exv31w2.htm EX-31.2 6785
5 EX-32.1: CERTIFICATION y26939exv32w1.htm EX-32.1 2879
6 EX-32.2: CERTIFICATION y26939exv32w2.htm EX-32.2 2968
  Complete submission text file 0000950123-06-013854.txt   446422
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15190 | Film No.: 061202098
SIC: 2835 In Vitro & In Vivo Diagnostic Substances